Common Infectious Agents and Monoclonal B-Cell Lymphocytosis: A Cross-Sectional Epidemiological Study among Healthy Adults

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Casabonne, Delphine ^a,b   Almeida, Julia ^c   Nieto, Wendy G ^c   Romero, Alfonso ^d   Fernández Navarro, Paulino ^e   Rodriguez Caballero, Arancha ^c   Muñoz Criado, Santiago ^f   Díaz, Marcos González ^g   Benavente, Yolanda ^a,b   de Sanjosé, Silvia ^a,b   Orfao, Alberto ^c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c CSIC   (Spain)

^d Centro de Salud Mental Miguel Armijo   (Spain)

^e Centro de Atención Primaria de Salud de Ledesma   (Spain)

^f HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^g UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FAMILY HISTORY; FEMALE; HEMATOLOGIC MALIGNANCY; HIGH RISK BEHAVIOR; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENINGITIS; MONOCLONAL B CELL LYMPHOCYTOSIS; PNEUMONIA; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIBLING; VACCINATION;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS;

EID: 84871671745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052808     Document Type: Article

References (28)

1. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, et al. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111: 5446-5456.
2. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, et al. (2005) Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 130: 325-332.
3. Dagklis A, Fazi C, Sala C, Cantarelli V, Scielzo C, et al. (2009) The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood 114: 26-32.
4. Fazi C, Scarfo L, Pecciarini L, Cottini F, Dagklis A, et al. (2011) General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood 118: 6618-6625.
5. Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, et al. (2009) Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 114: 33-37.
6. Almeida J, Nieto WG, Teodosio C, Pedreira CE, Lopez A, et al. (2011) CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults. Leukemia 25: 718-722.
7. Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, et al. (2009) B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 360: 659-667.
8. Rawstron AC, Bennett FL, O'Connor SJ, Kwok M, Fenton JA, et al. (2008) Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359: 575-583.
9. Rawstron AC, (2004) Prevalence and characteristics of monoclonal B-cell lymphocytosis (MBL) in healthy individuals and the relationship with clinical disease. J Biol Regul Homeost Agents 18: 155-160.
10. Slager SL, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, et al. (2011) Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 117: 1911-1916.
11. Shim YK, Vogt RF, Middleton D, Abbasi F, Slade B, et al. (2007) Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population. Cytometry B Clin Cytom 72: 344-353.
12. Marwick C, (2003) Link found between Agent Orange and chronic lymphocytic leukaemia. BMJ 326: 242.
13. Clarke CA, Glaser SL, Gomez SL, Wang SS, Keegan TH, et al. (2011) Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation. Cancer Epidemiol Biomarkers Prev 20: 1064-1077.
14. Wu SJ, Huang SY, Lin CT, Lin YJ, Chang CJ, et al. (2010) The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effect. Blood 116: 4430-4435.
15. Moreira J, Rabe KG, Cerhan JR, Kay NE, Wilson JW et al. (2012) Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. Leukemia Jul 11. doi: 0.1038/leu.2012.187.
16. Landgren O, Rapkin JS, Caporaso NE, Mellemkjaer L, Gridley G, et al. (2007) Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 109: 2198-2201.
17. Anderson LA, Landgren O, Engels EA, (2009) Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol 147: 444-449.
18. Landgren O, Gridley G, Check D, Caporaso NE, Morris BL, (2007) Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. Br J Haematol 139: 791-798.
19. Marti G, Abbasi F, Raveche E, Rawstron AC, Ghia P, et al. (2007) Overview of monoclonal B-cell lymphocytosis. Br J Haematol 139: 701-708.
20. Scarfo L, Dagklis A, Scielzo C, Fazi C, Ghia P, (2010) CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? Semin Cancer Biol 20: 384-390.
21. Ghia P, Chiorazzi N, Stamatopoulos K, (2008) Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med 264: 549-562.
22. Fazi C, Dagklis A, Cottini F, Scarfo L, Bertilaccio MT, et al. (2010) Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals. Cytometry B Clin Cytom 78Suppl 1: S61-S68.
23. Matos DM, Ismael SJ, Scrideli CA, de Oliveira FM, Rego EM, et al. (2009) Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia. Br J Haematol 147: 339-346.
24. Ekstrom SK, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, et al. (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111: 4029-4038.
25. Fortuny J, Benavente Y, Bosch R, Garcia-Villanueva M, de Sevilla AF, et al. (2005) Type 2 diabetes mellitus, its treatment and risk for lymphoma. Eur J Cancer 41: 1782-1787.
26. La Vecchia C, (2011) Diabetes mellitus, medications for type 2 diabetes mellitus, and cancer risk. Metabolism 60: 1357-1358.
27. Hauswirth AW, Almeida J, Nieto WG, Teodosio C, Rodriguez-Caballero A, et al. (2012) Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets. Am J Hematol 87: 721-724.
28. D'Arena G, Rossi G, Minervini MM, Savino L, D'Auria F, et al. (2011) Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis. Int J Immunopathol Pharmacol. 24(4): 915-923.